Particle.news

Download on the App Store

Federal Court Reviews Ban on Botox and Filler Before-and-After Ads

The decision will clarify whether displaying outcome photos for Botox or hyaluronic acid treatments violates Germany’s ban on comparative cosmetic surgery advertising.

Image
Der Bundesgerichtshof hat sich am Donnerstag mit dem Thema Schönheitsbehandlungen auseinandergesetzt.
Image
Am Bundesgerichtshof wird über die Frage verhandelt, ob für Schönheitsbehandlungen mit Vorher-Nachher-Darstellungen geworben werden darf.

Overview

  • On July 3, 2025, Germany’s Federal Court of Justice opened hearings to determine if before-and-after images for minimal-invasive treatments fall under the Heilmittelwerbegesetz advertising ban.
  • The case hinges on classifying Botox and hyaluronic acid injections as non-medically necessary plastic-surgical procedures prohibited from comparative advertising outside professional circles.
  • In August 2024, the Oberlandesgericht Hamm ruled that such before-and-after photos must be treated as unlawful operative surgery marketing.
  • Aesthetify, operated by Dr. Rick and Dr. Nick, has already ceased using these images but remains sued by Verbraucherzentrale Nordrhein-Westfalen over consumer protection concerns.
  • A Karlsruhe ruling is poised to shape how cosmetic clinics and influencers can use social media to showcase results and may prompt further marketing restrictions.